FDA moves to accelerate US clinical development as OIG weighs new protection for trial participant remuneration
Five Eyes Cybersecurity Agencies Issue Statement Regarding AI-Related Shifts in Cybersecurity Risks, Urging Organizational Leaders to “Act Now”
SEC exempts FPI directors and officers from Section 16 reporting obligations in certain jurisdictions